{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:53:47Z","timestamp":1759694027393,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R34 MH100776-01"],"award-info":[{"award-number":["R34 MH100776-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.schres.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T09:03:10Z","timestamp":1548406990000},"page":"414-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Gut permeability and mimicry of the Glutamate Ionotropic Receptor NMDA type Subunit Associated with protein 1 (GRINA) as potential mechanisms related to a subgroup of people with schizophrenia with elevated antigliadin antibodies (AGA IgG)"],"prefix":"10.1016","volume":"208","author":[{"given":"Daniela","family":"\u010cih\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica V.","family":"Talor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uasim H.","family":"Harkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Demyanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.schres.2019.01.007_bb0005","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1109\/TBME.2011.2161609","article-title":"Implementation of an absolute brain 1H-MRS quantification method to assess different tissue alterations in multiple sclerosis","volume":"59","author":"Bagory","year":"2012","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood-brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.schres.2019.01.007_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00380949","article-title":"Blood-cerebrospinal fluid barrier in schizophrenic patients","volume":"236","author":"Bauer","year":"1987","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"issue":"22","key":"10.1016\/j.schres.2019.01.007_bb0020","first-page":"3354","article-title":"Cingulate Cortex in Schizophrenia: its relation with negative symptoms and psychotic onset. A review study","volume":"18","author":"Bersani","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3\u20135","key":"10.1016\/j.schres.2019.01.007_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1993","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.schres.2019.01.007_bb0030","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1038\/tp.2015.43","article-title":"Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation","volume":"5","author":"Chiappelli","year":"2015","journal-title":"Transl. Psychiatry"},{"year":"2018","series-title":"Standardizing Gluten Sensitivity in Schizophrenia: Native Gliadin Antibody Measurement Compared to Deaminated Gliadin and Tissue Transglutaminase","author":"Cihakova","key":"10.1016\/j.schres.2019.01.007_bb0035"},{"key":"10.1016\/j.schres.2019.01.007_bb0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.schres.2017.08.051","article-title":"Gliadin-related antibodies in schizophrenia","volume":"195","author":"Cihakova","year":"2018","journal-title":"Schizophr. Res."},{"issue":"4\u20136","key":"10.1016\/j.schres.2019.01.007_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.schres.2019.01.007_bb0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ebiom.2015.08.019","article-title":"New brain lymphatic vessels drain old concepts","volume":"2","author":"Dissing-Olesen","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.schres.2019.01.007_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","article-title":"Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Mol. Autism"},{"issue":"5","key":"10.1016\/j.schres.2019.01.007_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/bies.201500143","article-title":"Extraintestinal manifestations of celiac disease: 33-mer gliadin binding to glutamate receptor GRINA as a new explanation","volume":"38","author":"Garcia-Quintanilla","year":"2016","journal-title":"BioEssays"},{"issue":"5","key":"10.1016\/j.schres.2019.01.007_bb0075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jnnp.72.5.560","article-title":"Gluten sensitivity as a neurological illness","volume":"72","author":"Hadjivassiliou","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(09)70290-X","article-title":"Gluten sensitivity: from gut to brain","volume":"9","author":"Hadjivassiliou","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2019.01.007_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med. Genet."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.01.007_bb0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2012.06.011","article-title":"A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies","volume":"140","author":"Jackson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11126-011-9186-y","article-title":"Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity","volume":"83","author":"Jackson","year":"2012","journal-title":"Psychiatry Q."},{"issue":"2\u20133","key":"10.1016\/j.schres.2019.01.007_bb0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.schres.2014.09.023","article-title":"Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia","volume":"159","author":"Jackson","year":"2014","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2019.01.007_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0269881112467089","article-title":"A review of anti-inflammatory agents for symptoms of schizophrenia","volume":"27","author":"Keller","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.01.007_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2017.10.020","article-title":"Anti gliadin antibodies (AGA IgG) related to peripheral inflammation in schizophrenia","volume":"69","author":"Kelly","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01250674","article-title":"Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia","volume":"89","author":"Kirch","year":"1992","journal-title":"J. Neural Transm. Gen. Sect."},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e31827b1a8c","article-title":"Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS","volume":"80","author":"Kirov","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0004-28032010000300006","article-title":"Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease","volume":"47","author":"Kotze","year":"2010","journal-title":"Arq. Gastroenterol."},{"issue":"9","key":"10.1016\/j.schres.2019.01.007_bb0130","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbamcr.2015.03.002","article-title":"The transmembrane Bax inhibitor motif (TMBIM) containing protein family: tissue expression, intracellular localization and effects on the ER CA(2)(+)-filling state","volume":"1853","author":"Lisak","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.schres.2019.01.007_bb0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3748\/wjg.v12.i2.292","article-title":"Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD","volume":"12","author":"Mallant-Hent","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.schres.2019.01.007_bb0140","first-page":"23","article-title":"Glutamate and schizophrenia","volume":"25","author":"Matute","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2019.01.007_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"Muller","year":"2015","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.schres.2019.01.007_bb0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/PSY.0000000000000352","article-title":"Kynurenine and tryptophan levels in patients with schizophrenia and elevated antigliadin immunoglobulin G antibodies","volume":"78","author":"Okusaga","year":"2016","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.schres.2019.01.007_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"7256","key":"10.1016\/j.schres.2019.01.007_bb0160","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.schres.2019.01.007_bb0165","article-title":"A role for oxytocin in the etiology and treatment of schizophrenia","volume":"33","author":"Rich","year":"2016","journal-title":"Trends Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.schres.2019.01.007_bb0170","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/cdd.2011.189","article-title":"TMBIM3\/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis","volume":"19","author":"Rojas-Rivera","year":"2012","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.schres.2019.01.007_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/brbi.2001.0648","article-title":"Review of immunological and immunopathological findings in schizophrenia","volume":"15","author":"Rothermundt","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2019.01.007_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fpsyt.2017.00104","article-title":"Antigliadin antibodies (AGA IgG) are related to neurochemistry in schizophrenia","volume":"8","author":"Rowland","year":"2017","journal-title":"Front. Psych."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.01.007_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2009.08.009","article-title":"Novel immune response to gluten in individuals with schizophrenia","volume":"118","author":"Samaroo","year":"2010","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2019.01.007_bb0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/mehy.2000.1203","article-title":"The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms","volume":"56","author":"Schwarz","year":"2001","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2012.02.025","article-title":"Gastrointestinal inflammation and associated immune activation in schizophrenia","volume":"138","author":"Severance","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2019.01.007_bb0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/08820139.2012.685537","article-title":"Spectrum of autoantibodies in Tunisian psychiatric inpatients","volume":"41","author":"Sidhom","year":"2012","journal-title":"Immunol. Investig."},{"issue":"1","key":"10.1016\/j.schres.2019.01.007_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"7256","key":"10.1016\/j.schres.2019.01.007_bb0210","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.schres.2019.01.007_bb0215","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood\u2013brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.01.007_bb0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1176\/ajp.142.5.657","article-title":"Permeability of the blood-brain barrier in psychiatric patients","volume":"142","author":"Torrey","year":"1985","journal-title":"Am. J. Psychiatry"},{"issue":"39","key":"10.1016\/j.schres.2019.01.007_bb0225","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1073\/pnas.0906773106","article-title":"Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2","volume":"106","author":"Tripathi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.01.007_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","article-title":"Ultrastructural damage of capillaries in the neocortex in schizophrenia","volume":"11","author":"Uranova","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.01.007_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.schres.2019.01.007_bb0245","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1021\/ac051916x","article-title":"Altered levels of acute phase proteins in the plasma of patients with schizophrenia","volume":"78","author":"Yang","year":"2006","journal-title":"Anal. Chem."},{"issue":"1\u20132","key":"10.1016\/j.schres.2019.01.007_bb0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000442934","article-title":"ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease?","volume":"34","author":"Zhou","year":"2016","journal-title":"Dig. Dis."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:43:32Z","timestamp":1565207012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"alternative-id":["S0920996419300076"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.01.007","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut permeability and mimicry of the Glutamate Ionotropic Receptor NMDA type Subunit Associated with protein 1 (GRINA) as potential mechanisms related to a subgroup of people with schizophrenia with elevated antigliadin antibodies (AGA IgG)","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}